Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine for transitioning glycaemic control in recovering critically ill patients
ACTRN12610000574044Phase 4Not yet recruiting
- Sponsor
- Canterbury District Health Board
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin glargine in Stress Hyperglycemia (SH) (2 arms), sponsored by Canterbury District Health Board. Primary endpoints: Goodness of blood glucose control, Total insulin administered and 1 more. Planned start Aug 2010; status: not yet recruiting.
02
Drugs
insulin glargine
03
Conditions
Stress Hyperglycemia (SH)
Beyond the preview
Go deeper on ACTRN12610000574044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000574044.